hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06307275 id: 5170221 briefTitle: Intermittent Fasting on Body Fat and Quality of Life overallStatus: RECRUITING date: 2024-03-11 date: 2024-12-31 date: 2024-12-31 date: 2024-03-12 date: 2024-04-12 name: Loma Linda University class: OTHER briefSummary: The purpose of this investigator-initiated study to check the feasibility that intermittent fasting has on body fat loss and quality of life. conditions: Healthy studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: CROSSOVER primaryPurpose: OTHER masking: NONE count: 70 type: ESTIMATED name: Fasting name: non fasting measure: Body fat percentage measure: Visceral fat sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Loma Linda University status: RECRUITING city: Loma Linda state: California zip: 92350 country: United States name: Gurinder Bains, PhD role: CONTACT phone: 909-558-4000 phoneExt: 87274 email: gbains@llu.edu lat: 34.04835 lon: -117.26115 hasResults: False
nctId: NCT06307262 id: EuroTR Registry briefTitle: European Registry of Transcatheter Repair for Tricuspid Regurgitation acronym: EuroTR overallStatus: RECRUITING date: 2023-10-23 date: 2030-12-31 date: 2030-12-31 date: 2024-03-12 date: 2024-03-15 name: LMU Klinikum class: OTHER briefSummary: To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement. conditions: Tricuspid Regurgitation conditions: Valvular Heart Disease conditions: Heart Failure studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: OTHER count: 3000 type: ESTIMATED name: T-TEER measure: All-cause mortality measure: Technical success measure: Procedural Safety measure: Heart Failure Biomarker measure: Dyspnea on exertion measure: Functional capacity measure: Right ventricular size measure: Right ventricular function measure: Tricuspid regurgitation reduction measure: Tricuspid valve stenosis measure: Pulmonary hypertension measure: Right heart congestion measure: Hospitalization for heart failure sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: LMU Klinikum status: RECRUITING city: Munich state: Bavaria zip: 81377 country: Germany name: Jörg Hausleiter, Prof. Dr. role: CONTACT phone: +49 89 4400 72360 email: Joerg.Hausleiter@med.uni-muenchen.de name: Lukas Stolz, Dr. role: CONTACT email: Lukas.Stolz@med.uni-muenchen.de lat: 48.13743 lon: 11.57549 hasResults: False
nctId: NCT06307236 id: E-41997688-050.99-105442 briefTitle: Dysmenorrhea of Emotional Freedom Techniques (EFT) and Its Effect on Perceived Stress Level overallStatus: ENROLLING_BY_INVITATION date: 2023-12-15 date: 2024-04-15 date: 2024-04-15 date: 2024-03-12 date: 2024-03-12 name: Kutahya Health Sciences University class: OTHER briefSummary: The aim of the study is to determine the effect of EFT application on the level of dysmenorrhea and stress perception in women with dysmenorrhea. For this purpose, EFT will be applied to women with dysmenorrhea with high stress perception assigned to the experimental and control groups, and their stress perceptions and dysmenorrhea levels will be re-evaluated after the application. Perceived Stress Scale (PSS) and Visual Analog Scale (VAS) will be used in the research. conditions: Dysmenorrhea Primary conditions: Stress conditions: Emotional Freedom studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomized Controlled Study primaryPurpose: SUPPORTIVE_CARE masking: SINGLE maskingDescription: Single Blinded whoMasked: PARTICIPANT count: 56 type: ESTIMATED name: Emotional Freedom Techniques measure: EFT application measure: Control sex: FEMALE minimumAge: 18 Years maximumAge: 49 Years stdAges: ADULT facility: Kütahya Health Science University city: Kütahya zip: 43000 country: Turkey lat: 39.42417 lon: 29.98333 hasResults: False
nctId: NCT06307223 id: 20240301 briefTitle: Efficacy and Safety of 30% Supramolecular Salicylic Acid Combined With Supramolecular Active Zinc in the Treatment of Malassezia Folliculitis overallStatus: COMPLETED date: 2022-06-07 date: 2023-09-20 date: 2023-09-20 date: 2024-03-12 date: 2024-03-12 name: Second Affiliated Hospital of Xi'an Jiaotong University class: OTHER briefSummary: Malassezia folliculitis is a common dermatological disorder. While antifungal agents generally demonstrate efficacy in application, the prevalence of recurrence and drug resistance remains a common occurrence. Supramolecular salicylic acid represents a novel class of superficial chemical peel agents, exhibiting keratolytic, anti-inflammatory, and bacteriostatic properties. Zinc pyrithione has broad spectrum antibacterial, antifungal, and anti-inflammatory effects. In the present study, investigators evaluated the clinical efficacy of topical application of supramolecular salicylic acid in combination with zinc pyrithione for the treatment and prevention of Malassezia folliculitis recurrence. All data are recorded and compared after the end of the experiment. The enrolled patients received daily application of topical supramolecular active zinc anti-dandruff lotion, in conjunction with weekly application of 30% supramolecular salicylic acid, for a duration of 8 weeks. Lesion counts, Malassezia detection, clinical symptom scores, patient satisfaction, and side effects were recorded at each visit till the week 12. conditions: Malassezia Folliculitis studyType: INTERVENTIONAL phases: PHASE4 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 21 type: ACTUAL name: 30% supramolecular salicylic acid name: supramolecular active zinc measure: lesion counts measure: The reduction rate of lesion counts measure: Clinical efficacy measure: Clinical symptoms scores sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: The Second Affiliated Hospital of Xi'an Jiaotong University city: Xi'an state: Shaanxi zip: 710000 country: China lat: 34.25833 lon: 108.92861 hasResults: False
nctId: NCT06307210 id: coreset_2020_2022 briefTitle: Is Inpatient Rehabilitation Effective for Very Old Patients? overallStatus: COMPLETED date: 2020-01-01 date: 2022-12-31 date: 2023-01-01 date: 2024-03-12 date: 2024-03-12 name: Klinik Valens class: OTHER briefSummary: The goal of this retrospective longitudinal observational study is to compare the effects of physical and mental performance as well as quality of life in patients with neurological and musculoskeletal disorders.
Researchers will compare the age group 75 to 84 and 85 to 99 to see if physical and mental performance as well as quality of life will improve. conditions: Activity, Motor conditions: Elderly Patients conditions: Musculoskeletal Diseases studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 2270 type: ACTUAL name: inpatient rehabilitation measure: FIM measure: TUG measure: EQ-5D (Quality of life) measure: PROMIS sex: ALL minimumAge: 75 Years maximumAge: 100 Years stdAges: OLDER_ADULT facility: Klinik Valens city: Valens state: Saint Gallen zip: CH-7317 country: Switzerland lat: 46.96658 lon: 9.47705 hasResults: False
nctId: NCT06307197 id: INRCA_008_2023 briefTitle: HAAL: HeAlthy Ageing Eco-system for peopLe With Dementia acronym: HAAL overallStatus: RECRUITING date: 2023-10-02 date: 2024-04-15 date: 2024-04-15 date: 2024-03-12 date: 2024-03-12 name: Istituto Nazionale di Ricovero e Cura per Anziani class: OTHER briefSummary: HAAL project aims to test several technological devices in order to improve the quality of life of older people with dementia and their informal and formal caregiver. conditions: Dementia conditions: Devices conditions: Artificial Intelligence conditions: Older People conditions: Caregiver Burden studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: OTHER masking: NONE count: 10 type: ESTIMATED name: HAAL platform measure: Care load of caregivers sex: ALL minimumAge: 65 Years stdAges: OLDER_ADULT facility: IRCCS INRCA Hospital status: RECRUITING city: Ancona country: Italy name: Elvira Maranesi role: CONTACT email: e.maranesi@inrca.it name: Roberta Bevilacqua role: PRINCIPAL_INVESTIGATOR lat: 43.5942 lon: 13.50337 hasResults: False
nctId: NCT06307184 id: 2301-LIS-007-AN briefTitle: Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer overallStatus: RECRUITING date: 2024-02-23 date: 2024-10 date: 2025-07 date: 2024-03-12 date: 2024-03-12 name: Instituto Valenciano de Infertilidade de Lisboa class: NETWORK name: Gedeon Richter Ltd. briefSummary: This study will assess the convenience of the natural proliferative phase frozen embryo transfer (NPP-FET) in terms of number of number of appointments needed before cycle scheduling. conditions: Frozen Embryo Transfer studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: OTHER count: 530 type: ESTIMATED name: Natural proliferative phase frozen embryo transfer measure: Number of appointments needed before cycle scheduling measure: Cycle duration until embryo transfer (days) measure: Proportion of patients with low progesterone values on the day of embryo transfer measure: Human corionic gonadotropin (hCG) positive rate measure: Miscarriage rate measure: Ongoing pregnancy rate measure: Live birth rate measure: Serum Relaxin-2 levels measure: Serum Luteinizing Hormone (LH) levels sex: FEMALE minimumAge: 18 Years maximumAge: 49 Years stdAges: ADULT facility: Instituto Valenciano de Infertilidade status: RECRUITING city: Lisboa country: Portugal name: Samuel Santos-Ribeiro, MD PhD role: CONTACT lat: 38.71667 lon: -9.13333 hasResults: False
nctId: NCT06307171 id: 2023-11 briefTitle: Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers acronym: LeishmARPs overallStatus: RECRUITING date: 2023-05-22 date: 2026-11 date: 2026-11 date: 2024-03-12 date: 2024-03-12 name: IRCCS Sacro Cuore Don Calabria di Negrar class: OTHER briefSummary: This is an exploratory experimental multicentre study on archived serum samples and on prospectively collected serum samples and blood samples.
General objectives of the study are: to identify specific biomarkers in order to develop more accurate serological tests for the screening of Leishmania infections that does not present cross-reaction with other infectious diseases; to unveil the Antigen Recognition Patterns (ARPs) of Leishmania infection in humans; to verify whether the ARPs and the new biomarkers are common to different Leishmania infantum strains isolated in Italy as well as in other part of the World and to different strains of L. donovani isolated in Sudan as well as in other part of the World and discard any possible cross reaction with other infectious diseases such as Chagas, TB, leprosy or malaria. conditions: Leishmaniasis studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: SINGLE_GROUP primaryPurpose: DIAGNOSTIC masking: NONE count: 170 type: ESTIMATED name: In-house Western blot, specific for Leishmania measure: Biomarkers from Leishmania spp measure: ARPs in different Leishmania infantum and L. donovani strains measure: Cross reaction sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: IRCCS Sacro Cuore Don Calabria hospital status: RECRUITING city: Negrar state: Verona zip: 37024 country: Italy name: Silvia Longoni role: CONTACT phone: +390456013111 email: silvia.longoni@sacrocuore.it name: Silvia Longoni role: PRINCIPAL_INVESTIGATOR lat: 45.52918 lon: 10.93899 hasResults: False
nctId: NCT06307158 id: CT2024-ZJU-OBS1 briefTitle: Influence of Intraoperative Blood Salvage and Autotransfusion on Tumor Recurrence After Deceased Donor Liver Transplantation overallStatus: COMPLETED date: 2015-01-01 date: 2020-12-31 date: 2021-12-31 date: 2024-03-12 date: 2024-03-12 name: Zhejiang University class: OTHER name: Shulan (Hangzhou) Hospital briefSummary: The practice of intraoperative blood salvage and autotransfusion (IBSA) during deceased donor liver transplantation (DDLT) for hepatocellular carcinoma (HCC) can potentially reduce the need for allogeneic blood transfusion. However, implementing IBSA remains debatable due to concerns about its possible detrimental effects on oncologic recurrence. Hence, a nationwide multi-center study was conducted to investigate further the association between IBSA and post-transplant HCC recurrence, including a stratified subgroup analysis. conditions: Liver Transplant; Complications studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 998 type: ACTUAL measure: Postoperative recurrence of liver cancer sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06307145 id: K-NHIS-HIP briefTitle: Korea Hip Replacement Surgery Registry overallStatus: COMPLETED date: 2003-01-01 date: 2020-12-31 date: 2020-12-31 date: 2024-03-12 date: 2024-03-12 name: Samsung Medical Center class: OTHER briefSummary: This cohort study obtained data from the Korean National Health Insurance Service (K-NHIS) database. For the hip replacement registry, we included all adult patients older than 19 who received total or hemiarthroplasty surgery between January 1, 2003, and December 31, 2019. Using this registry, we compared efficacy and safety by type of head or liner. conditions: Hip Replacement Surgery studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 124556 type: ACTUAL measure: Cancer sex: ALL minimumAge: 19 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06307132 id: SAHoWMU-CR2024-03-106 briefTitle: Drug Metabolism, Excretion, and Human Body Composition of Aximus Capsules overallStatus: ACTIVE_NOT_RECRUITING date: 2024-01-31 date: 2024-06-30 date: 2024-08-31 date: 2024-03-12 date: 2024-03-12 name: Second Affiliated Hospital of Wenzhou Medical University class: OTHER briefSummary: This project will be based on the bioequivalence test of Aximus capsules, measuring the body composition indicators of healthy subjects before and after medication, and collecting urine samples from subjects at different time periods after medication, measuring urine drug concentration, calculating urine excretion, analyzing the individualized differences in metabolism and excretion of Aximus capsules under different health states of human components, and providing guidance for clinical precision medication. conditions: Bioequivalence Trial studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: PROSPECTIVE count: 26 type: ESTIMATED name: Aximus capsules（test） name: Aximus capsules（reference） measure: Excretion volume sex: ALL minimumAge: 18 Years maximumAge: 55 Years stdAges: ADULT facility: The Second Affiliated Hospital of WMU Phase l Clinical Trial Unit /Center Of Bioequivalence Study city: Wenzhou country: China lat: 27.99942 lon: 120.66682 hasResults: False
nctId: NCT06307119 id: 2020-01 briefTitle: Model of Human Occupation-Based Intervention on Premenstrual Syndrome Symptoms overallStatus: COMPLETED date: 2023-03-01 date: 2024-03-01 date: 2024-03-02 date: 2024-03-12 date: 2024-03-12 name: Saglik Bilimleri Universitesi class: OTHER briefSummary: This study was conducted to examine the effect of two different occupational therapy interventions on premenstrual syndrome symptoms in university students. This study was designed according to the CONSORT statement, which provides a standard method for randomised controlled trial (RCT) design. The study was approved by the Local Ethics Committee. Written informed consent was obtained from all participants before the study. conditions: Premenstrual Syndrome studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 95 type: ACTUAL name: Occupational Therapy and Relaxation Group name: Relaxation Group measure: Occupational Self-Assessment measure: The Model of Human Occupation Screening Tool (MOHOST) measure: Premenstrual Symptom Screening Tool sex: FEMALE minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Health Sciences Turkey city: Ankara country: Turkey lat: 39.91987 lon: 32.85427 hasResults: False
nctId: NCT06307106 id: #40\14-Jan-2024 briefTitle: Various Strategies to Reduce Acute Post Hemorrhoidectomy Pain: A Comparative Study overallStatus: ACTIVE_NOT_RECRUITING date: 2024-01-14 date: 2024-07-14 date: 2024-07-14 date: 2024-03-12 date: 2024-03-12 name: Zagazig University class: OTHER_GOV briefSummary: Since post hemorrhoidectomy pain is a severe and common post operative symptom so there is a need to find a suitable method for reducing this pain, up to our knowledge, this the first study in ZUH to compare between ketrolac, light Marcaine, corticosteroids and diclofenac sodium injection at surgical site for relieve of post operative pain. This is a randomizes comparative prospective clinical trial. conditions: Acute Post Operative Pain studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: SINGLE whoMasked: PARTICIPANT count: 120 type: ACTUAL name: ketorolac and light marcaine name: light marcaine name: Corticosteroids injection name: Diclofenac Sodium Gel measure: age measure: sex measure: number of hemorrhoids measure: degree of hemorroids measure: post operative pain measure: ambulation measure: return to work measure: patient satisfaction sex: ALL minimumAge: 18 Years maximumAge: 60 Years stdAges: ADULT facility: Zagazig University Hospitals city: Zagazig zip: 44519 country: Egypt lat: 30.58768 lon: 31.502 hasResults: False
nctId: NCT06307093 id: CL01860198 briefTitle: Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms overallStatus: ACTIVE_NOT_RECRUITING date: 2023-03-01 date: 2023-12-11 date: 2025-07 date: 2024-03-12 date: 2024-03-12 name: R-Pharm class: INDUSTRY name: Data Management 365 name: Exacte Labs LLC name: Federal State Budgetary Institution "NMIC of Hematology" of the Ministry of Health of the Russian Federation name: Federal State Budgetary Institution of the Central Research Institute of Epidemiology of Rospotrebnadzor briefSummary: The goal of this double-blind, randomized study is to establish the equivalence of pharmacokinetic properties, as well as the comparability of safety, immunogenicity and pharmacodynamics of the drug RPH-075 (international nonproprietary name (INN) is pembrolizumab) in comparison with the drug Keytruda® (INN is pembrolizumab) after a single intravenous injection to patients with malignant neoplasms as a first or second line therapy in a monotherapy regimen.
nctId: NCT06307080 id: IIT2023-064 briefTitle: Clinical Study of Multi-mode Thermal Ablation for the Treatment of Pancreatic Cancer With Liver Metastasis overallStatus: RECRUITING date: 2023-10-08 date: 2024-12-31 date: 2024-12-31 date: 2024-03-12 date: 2024-03-12 name: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine class: OTHER briefSummary: 1. Clinical evaluation of multimodal ablation system for pancreatic cancer with hepatic metastatic malignancies.
3. Transformation and clinical application of multimodal ablation system for pancreatic cancer with hepatic metastatic malignancies. conditions: Pancreatic Cancer studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 12 type: ESTIMATED name: Multi-mode thermal ablation device name: Intravenous anti-PD-1 and chemotherapy measure: Safety and efficacy assessment measure: Survival benefit measure: The application of medical-mechanical combination therapy mode sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Shanghai General Hospital status: RECRUITING city: Shanghai state: Shanghai zip: 200040 country: China name: Jiang Long, MD role: CONTACT phone: +86 18017317460 email: jiang.long@shgh.cn lat: 31.22222 lon: 121.45806 hasResults: False
nctId: NCT06307067 id: URINDO briefTitle: Improving Care for Uncomplicated URinary Tract Infection-associated Symptoms in Primary Healthcare Settings in INDOnesia acronym: URINDO overallStatus: NOT_YET_RECRUITING date: 2024-03-04 date: 2024-11-04 date: 2025-06-01 date: 2024-03-12 date: 2024-03-12 name: Erasmus Medical Center class: OTHER name: Saiful Anwar Hospital name: Brawijaya University, Malang, Indonesia name: Diponegoro University/Diponegoro National Hospital, Semarang, Indonesia name: Bali Mandara Hospital, Denpasar, Bali, Indonesia briefSummary: In the present study, we aim to analyze the impact of the introduction of a urinary dipstick test for patients presenting with uncomplicated UTI-associated symptoms on antibiotic prescription in primary health care in Indonesia. In addition, the knowledge of HCW regarding antibiotics and prudent use of antibiotics in the community setting will be investigated.
2. To analyze the knowledge level of healthcare workers on uncomplicated UTI and prudent antibiotic use in primary health care settings in Indonesia. conditions: Urinary Tract Infections studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: PROSPECTIVE count: 300 type: ESTIMATED name: Urine dipstick measure: appropriateness of prescriptions for uncomplicated UTI-associated symptoms in the primary health care settings in Indonesia sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Erasmus Medical Center city: Rotterdam state: Zuid-Holland zip: 3015 GD country: Netherlands lat: 51.9225 lon: 4.47917 hasResults: False
nctId: NCT06307054 id: SHSY-CAR-NK-AML01 briefTitle: CLL-1 CAR-NK Cells for Relapsed/Refractory AML overallStatus: RECRUITING date: 2024-03-15 date: 2026-03-15 date: 2027-03-15 date: 2024-03-12 date: 2024-03-12 name: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine class: OTHER briefSummary: This study is a single-arm, open-label, dose-escalation clinical trial aimed at exploring the safety, tolerability, and pharmacokinetic characteristics of the CLL-1 CAR NK cells, as well as providing preliminary observations on its efficacy in subjects with relapsed/refractory acute myeloid leukemia. conditions: Relapsed Adult AML conditions: Refractory AML studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 24 type: ESTIMATED name: anti-CLL-1 CAR NK cells measure: AE measure: DLT measure: Peak Plasma Concentration (Cmax) measure: PD measure: Complete response measure: Duration of response (DOR) measure: Progression-free survival (PFS) measure: Overall survival (OS) measure: Number of participants with treatment-related AEs as assessed by CTCAE v5.0 sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Shanghai General Hospital status: RECRUITING city: Shanghai state: Shanghai zip: 200080 country: China name: Xianmin Song, MD role: CONTACT phone: +86 21 63240090 phoneExt: 3175 email: shongxm@139.com name: Xianmin Song, MD role: PRINCIPAL_INVESTIGATOR lat: 31.22222 lon: 121.45806 hasResults: False